Wenxin He

机构：Jinan University, Sichuan Agricultural University · ORCID：0000-0002-8249-968X

发表论文 123 篇 · 总被引 1663 次 · h-index 23

代表论文

• YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis (2024 · Experimental & Molecular Medicine · 被引 37)
• Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study (2024 · Signal Transduction and Targeted Therapy · 被引 35)
• Genomic and functional diversity of the human-derived isolates of Faecalibacterium (2024 · Frontiers in Microbiology · 被引 17)
• Neoadjuvant Aumolertinib for unresectable stage III EGFR-mutant non-small cell lung cancer: a single-arm phase II trial (2025 · Nature Communications · 被引 15)
• Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial (2025 · Nature Communications · 被引 15)
• Intestinal L-cell mechanoreception regulates hepatic lipid metabolism through GLP-1 (2025 · Science Advances · 被引 10)